Home » FDA » Recent Articles:

Water Cooler News Links for July 13, 2010

written by CCI July 13, 2010 Water Cooler

Among today’s news links: BP to start Gulf well test by midday Tuesday; The Billion Dollar Man; Obama’s debt commission warns of fiscal “cancer”.

Water Cooler News Links for July 12th, 2010

written by CCI July 12, 2010 Water Cooler

Among today’s news links: Obama may review regulations affections businesses; FDA review spotlights heart risk of diabetes pill; and Wall Street hiring in anticipation of economic recovery.

Water Cooler: News Links for June 18, 2010

written by CCI June 18, 2010 Water Cooler

Among today’s Water Cooler stories: Elliot Wave predicts triple-digit Dow (90% drop from right now) in 2016; Fixing the CPI; How the Liability Cap Helped Cause the Gulf Spill; and, The best and worst states for new businesses [infographic].

Water Cooler Links for June 15, 2010

written by Jerod Morris June 15, 2010 Water Cooler

Among the stories being discussed at water coolers across the land today: BP May Lose Oil Leases, Contracts After Spill; F.B.I. Opens Kennedy File; and North Carolina congressman, Bob Etheridge, gets physical with reporter (watch the pretty shocking video).

Coming Soon! FDA’s Current Thinking on Social Media and Product Promotion

Coming Soon! FDA’s Current Thinking on Social Media and Product Promotion

This article by Areta Kupchyk and Keven Madagan of Reed Smith explains why even though various business sectors have fervently embraced social media as a product marketing tool, FDA-regulated industries have been slow to adopt this practice.

The Top Five Corporate Compliance Challenges of 2010

written by Mark Srere May 24, 2010 Compliance, Featured Article
The Top Five Corporate Compliance Challenges of 2010

Corporate compliance, difficult in the best of times, presents even more challenges in an economic downturn. This article by Mark Srere sets forth the top five challenges that a company’s compliance department may face in 2010.

Top Five Compliance Risks Facing Life Sciences Companies

Top Five Compliance Risks Facing Life Sciences Companies

Scott Bruns and Kathleen Meriwether of Ernst & Young count down the top five compliance risks facing life sciences companies, including sales & marketing risks, the FCPA and IFRS, as well as supply-chain integrity and aggregate spend.

Categories

FCPA Compliance: Featured Column by Mike Koehler

Archives

Upcoming Event